Australian Logistics Stock News

Civmec (ASX:CVL) has laid out a fresh set of H1 2026 numbers, with the latest half showing total revenue of A$307.7 million and basic EPS of A$0.03 alongside net income of A$16.0 million. Over recent halves the company has seen revenue move from A$541.1 million and EPS of A$0.06 in H2 2024 to A$502.9 million and EPS of A$0.05 in H1 2025. This sets the backdrop for today’s update and the current share price of A$1.56, and investors are now weighing those headline figures against slightly...

Cochlear (ASX:COH) has reported its H1 2026 results with trailing twelve month revenue of A$2.3b and basic EPS of A$5.28, giving investors a clear read on both top line scale and earnings power. The company has seen half year revenue move from A$1,137.1 million in H2 2024 to A$1,171.8 million in H1 2025 and A$1,171.3 million in H2 2025, while basic EPS shifted from A$2.53 to A$3.13 and then A$2.81 over the same periods. This sets the backdrop for a margin story that investors will parse...

In recent days, Telstra Group has urged the Australian Treasury to impose a hard cap on industry-wide spectrum licence renewal fees, arguing that current proposed valuations are inflated and could force difficult trade-offs in future mobile network investment. This regulatory push lands just as Telstra approaches its half-year results and key consultation deadlines, sharpening investor attention on how potential spectrum costs could influence the company’s capital allocation and long-term...

In recent days, Technology One reported that 30,270 options and 3,800 performance rights had lapsed after their performance or service conditions were not met, slightly trimming potential future share issuance with little impact on the overall capital structure. At the same time, Technology One has appeared on an ASX downtrends list in technical trading scans, a development that may influence investor sentiment more than the relatively minor equity incentive lapses. We’ll now examine how...

Nick Scali (ASX:NCK) has released its H1 2026 scorecard, with investors already eyeing how the latest numbers fit into the broader trend in revenue and EPS. The company has seen half year revenue move from A$241.6 million in H2 2024 to A$251.1 million in H1 2025 and then A$244.2 million in H2 2025, while basic EPS shifted from A$0.457 to A$0.351 and then A$0.324 over the same periods. This gives investors a clear view of how recent trading has flowed through to the bottom line. With net...

Why Suncorp Group is back in focus after its latest earnings Suncorp Group (ASX:SUN) has drawn fresh attention after reporting earnings growth while keeping its spot in the ASX 50 Index, as it continues tying together its insurance and banking operations. See our latest analysis for Suncorp Group. Despite earnings growth and operational integration efforts, Suncorp Group’s recent momentum has cooled. The 30 day share price return of 6.29% and year to date share price return of 10.45% are both...

GQG Partners Inc. has reported full-year 2025 results, with revenue rising to US$808.3 million and net income to US$463.3 million, while its board declared a fourth-quarter dividend of US$0.0365 per share, equal to 90% of fourth-quarter distributable earnings. These results came alongside record funds under management growth driven by investment performance, even as the firm continued to face ongoing net outflows and adjusted distribution policies affecting how income, capital gains, and...

Boab Metals (ASX:BML) has moved into focus after securing final works approvals for full construction at its Sorby Hills silver, lead and zinc project, marking a key step toward potential future production. See our latest analysis for Boab Metals. Those approvals and recent capital moves, including a A$60m follow on equity offering at A$0.40 and new director shares tied to Sorby Hills permits, come after strong momentum. The company has recorded a 90 day share price return of 52.38% and a...

Santos (ASX:STO) has reported higher proved plus probable reserves and larger carbon capture and storage resources, placing its emissions management plans alongside core production firmly in focus for investors tracking sustainability themes. See our latest analysis for Santos. At a share price of A$6.70, Santos has had a 6.18% 1 month share price return and an 8.94% year to date share price return. Meanwhile, the 1 year total shareholder return of 1.26% and 5 year total shareholder return of...

In the past quarter, James Hardie Industries plc reported third-quarter 2025 sales of US$1,239.8 million, up from US$953.3 million a year earlier, while net income fell to US$68.7 million from US$141.7 million and basic earnings per share from continuing operations declined to US$0.12 from US$0.33. Despite the weaker headline profit, the company exceeded analyst expectations for adjusted earnings and revenue, highlighting strong sales growth supported by the early benefits of its AZEK...

ANZ Group Holdings (ASX:ANZ) is back in focus after revealing first quarter costs came in lower than analysts had expected, a surprise that has sharpened attention on the bank’s efficiency and profit potential. See our latest analysis for ANZ Group Holdings. The cost surprise has arrived on top of strong recent momentum, with ANZ’s 7 day share price return of 10.48% and 30 day share price return of 12.40% adding to a 1 year total shareholder return of 37.44%. This suggests sentiment has been...

G8 Education recently announced a large A$350,000,000 non-cash goodwill impairment for FY25, alongside suspending its final dividend and pausing its on-market share buyback in response to weaker sector conditions and softer earnings expectations. Despite these conservative capital measures, the company has reaffirmed its FY25 EBIT guidance, underscoring management’s view that underlying operations remain broadly stable even as accounting values are reset. We’ll now examine how this sizeable...

Why Michael Powell’s appointment matters for DroneShield DroneShield (ASX:DRO) has appointed Michael Powell as Chief Operating Officer, following a period of accelerated expansion, rising demand from defence, government and critical infrastructure customers, and a major manufacturing build out in Alexandria, New South Wales. See our latest analysis for DroneShield. The appointment comes as the A$3.03 share price sits below recent highs, with a 30 day share price return of a 24% decline...

Westpac Banking Corporation has reported first-quarter FY26 unaudited statutory net profit of A$1.90 billion, with revenue rising as higher net interest income offset softer non-interest income, alongside growth in lending and deposits. The bank also highlighted progress in its technology agenda, including company-wide AI training and new digital platforms, which management links to better customer service, productivity and operational resilience. We’ll now examine how Westpac’s profit...

Viva Leisure (ASX:VVA) has set out its H1 2026 picture with investors looking closely at how its recent run of numbers stacks up, after the company booked H2 2025 revenue of A$112.3 million with basic EPS of A$0.0329 and net income of A$3.3 million, on top of H1 2025 revenue of A$99.0 million and EPS of A$0.0195. Over recent halves the company has seen revenue move from A$83.5 million and EPS of A$0.0187 in H2 2024 to A$99.0 million and A$0.0195 in H1 2025, before reaching A$112.3 million and...

MFF Capital Investments (ASX:MFF) has released its H1 2026 scorecard, with recent half-year figures showing H2 2025 revenue of A$68.5 million and basic EPS of A$0.09, alongside H1 2025 revenue of A$562.9 million and basic EPS of A$0.66. These are set against H2 2024 revenue of A$449.6 million and basic EPS of A$0.52. The company has also reported trailing 12‑month revenue of A$631.4 million with basic EPS of A$0.74 in H2 2025 and A$1.18 on A$1.0 billion of revenue in H1 2025, giving investors...

In February 2026, Mesoblast reported data from patients treated under the U.S. Emergency Investigational New Drug program showing that its FDA-approved cell therapy Ryoncil® (remestemcel-L-rknd) achieved similarly high survival outcomes in steroid-refractory acute graft-versus-host disease across children and adults, at different treatment lines and regardless of ruxolitinib use or resistance. The findings, which highlighted better completion of treatment and survival when Ryoncil was used...

Insurance Australia Group (ASX:IAG) has put up another set of solid headline numbers for H1 2026, with trailing twelve month revenue of about A$17.4b and basic EPS of A$0.57 coming off net income of A$1,359m, while the latest reported half in 2025 delivered revenue of A$8.7b and EPS of A$0.25 on net income of A$581m. Over the past few reported halves the company has seen revenue move from A$8.1b in H2 2024 to A$8.7b in H1 2025 and A$8.7b in H2 2025, alongside EPS shifting from A$0.21 to...

Oneview Healthcare (ASX:ONE) has put fresh numbers on the table for FY 2025, reporting first half revenue of €6.3 million and a basic EPS loss of €0.01. Trailing twelve month revenue stands at €11.6 million with a basic EPS loss of €0.016452. Over recent periods the company’s revenue has moved from €4.7 million in the first half of 2024 to €5.2 million in the second half of 2024 and then to €6.3 million in the first half of 2025. Across the same periods, half year basic EPS figures have...

CAR Group (ASX:CAR) is back in focus after its latest half year earnings, where revenue reached A$625.79 million and net profit came in at A$143.34 million, alongside a higher interim dividend. See our latest analysis for CAR Group. Despite the solid half year update and higher dividend, the share price has had a tougher run, with a 30 day share price return of a 17.67% decline and a year to date share price return of an 18.79% decline. The 1 year total shareholder return of a 32.67% decline...

Northern Star Resources (ASX:NST) has reported another solid set of numbers for H1 2026, with the latest reported half year in H2 2025 showing revenue of A$3.5b and basic EPS of A$0.68, underpinned by net income of A$833.3m. The company has seen revenue move from A$2.7b and EPS of A$0.38 in H2 2024 to A$2.9b and EPS of A$0.44 in H1 2025, then to A$3.5b and EPS of A$0.68 in H2 2025. This sets up a trailing twelve month net income of A$1.5b and EPS of A$1.16. With net profit margins running at...

In early 2026, Electro Optic Systems (EOS) issued a detailed rebuttal to US short seller Grizzly Research’s report, clarifying its cash position, explaining that a disputed US$80 million South Korean high‑energy laser contract is conditional and excluded from its confirmed A$459 million order backlog, and defending the MARSS Group acquisition. At the same time, EOS signed a collaboration agreement with Turkish defence company ROKETSAN and disclosed a conditional high‑energy laser contract in...

Pro Medicus (ASX:PME) has just posted its H1 2026 scorecard, headlined by trailing 12 month revenue of A$241.1 million alongside basic EPS of A$2.25, as the company continues to convert its imaging software footprint into solid top and bottom line figures. The company has seen revenue move from A$184.6 million to A$241.1 million across recent trailing 12 month periods, with basic EPS stepping up from A$0.94 to A$2.25 over the same horizon. Reported net profit margin has shifted sharply higher...

AMP (ASX:AMP) has put fresh numbers on the table for FY 2025, reporting first half revenue of A$1.4 billion and basic EPS of A$0.039. This helps set the tone for how the year is shaping up after a mixed FY 2024. The company reported revenue of A$1.4 billion in the first half of 2024 and a loss of A$392 million in the second half. Over the same period, basic EPS moved from A$0.0387 to A$0.0185, before reaching A$0.039 in the latest half. For investors, a key focus now is how these results...